6Calabro P, YehTH. The pleiotropic effects of statins [J]. Curr Opin Cardiol, 2005,20(6) :541-546.
7Planavila A, Laguna JC, V:azquez-Carrera M, et al.Atorvastrtin improves peroxisome proliferator-activa- ted receptor signaling in cardiac hypertrophy by preventingnuclearfactor-r. Bactivation[J]. Biochimica Biophysica Acta, 2005,1687 : 76-83.
8The Long term Intervention with Pravastatin in lschemic Di sease(LIPID)Study Group. Prevention of cardiovasculsr events and death With pravastatin in pa- tients with coronary head disease and abroad range of initial cholesterol levels[J], N Engl J Med, 1998,339 : 1 349-1 357.
9Kishi T, Hirooka Y, Mukai Y, et al. Atorvastatin causes depressor and sympathy inhibitory effects with upregulation of nitric oxide syntheses in stroke-prone Spontaneously hypeltensive rats [J]. J Hypedension, 2003,21: 379-386.
10Wong B, Lumma WC, Smith AM, et al. Statins suppress THP lcell migration and secretion of matrix metallopmteinase 9 by inhibiting geranylgeranylation [J]. J Leukoc Biol, 2001,69 : 959-962.
1Satter N,Preiss D,Murray HM. Statins and risk of incident diabeters:a collaborative meta-analysis of randomised statin trials[J].{H}LANCET,2010,(9716):735-742.
2Gillett RC Jr,Norrell A. Consideration for safe use of statins:liver enzyme abnormalities and muscle toxicilitiy[J].{H}American Family Physician,2011,(06):711-716.
